GE to expand in life sciences with buyout of strategic assets from Thermo Fisher Scientific
MLex Summary: General Electric announced that its division GE Healthcare will acquire Thermo Fisher’s HyClone cell culture media and sera, as well as gene modulation and magnetic beads businesses for around...To view the full article, register now.
Already a subscriber? Click here to view full article